OmniAb signs global ion channel collaboration deal with Eli Lilly, eyes up to $370 million in milestones - OABI News | RalliesOmniAb signs global ion channel collaboration deal with Eli Lilly, eyes up to $370 million in milestones
O
OABI• OmniAb and Eli Lilly sign global ion channel collaboration
- OmniAb entered a global collaboration and license agreement with Eli Lilly for a new ion channel discovery program.
- The deal includes an upfront payment. OmniAb can earn up to $370 million in research, development and commercial milestones.
- The agreement also provides tiered royalties on global net sales.
- The therapeutic target and modality were not disclosed.
